Y Intercept Hong Kong Ltd Has $3.61 Million Stock Holdings in Omega Healthcare Investors, Inc. $OHI

Y Intercept Hong Kong Ltd increased its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 25.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 85,461 shares of the real estate investment trust’s stock after purchasing an additional 17,475 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Omega Healthcare Investors were worth $3,608,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of OHI. Caitong International Asset Management Co. Ltd bought a new position in Omega Healthcare Investors during the second quarter worth about $26,000. Smartleaf Asset Management LLC lifted its position in Omega Healthcare Investors by 40.9% in the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 268 shares in the last quarter. CENTRAL TRUST Co boosted its position in shares of Omega Healthcare Investors by 1,654.4% during the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 943 shares during the period. Salem Investment Counselors Inc. bought a new position in shares of Omega Healthcare Investors during the 3rd quarter worth approximately $39,000. Finally, Bayforest Capital Ltd grew its position in Omega Healthcare Investors by 395.2% in the second quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock valued at $41,000 after purchasing an additional 901 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Performance

NYSE OHI opened at $44.00 on Tuesday. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.04 and a fifty-two week high of $46.36. The stock has a market cap of $13.00 billion, a PE ratio of 24.58, a PEG ratio of 1.41 and a beta of 0.57. The company has a debt-to-equity ratio of 0.95, a quick ratio of 7.11 and a current ratio of 7.11. The firm’s fifty day moving average price is $44.70 and its two-hundred day moving average price is $42.35.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.02. The firm had revenue of $311.59 million for the quarter, compared to analyst estimates of $262.48 million. Omega Healthcare Investors had a return on equity of 10.72% and a net margin of 46.83%.The business’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same period last year, the firm posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on OHI. Jefferies Financial Group restated a “hold” rating and set a $45.00 target price on shares of Omega Healthcare Investors in a report on Monday, December 15th. The Goldman Sachs Group assumed coverage on shares of Omega Healthcare Investors in a report on Friday, January 9th. They set a “buy” rating and a $54.00 target price for the company. UBS Group boosted their price objective on Omega Healthcare Investors from $50.00 to $51.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Citigroup restated a “buy” rating and issued a $50.00 price target (up from $45.00) on shares of Omega Healthcare Investors in a research note on Wednesday, November 12th. Finally, BMO Capital Markets cut Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 price target for the company. in a research note on Friday, January 9th. Seven investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $47.09.

Insider Buying and Selling at Omega Healthcare Investors

In related news, CIO Vikas Gupta bought 11,500 shares of the stock in a transaction that occurred on Thursday, November 6th. The stock was acquired at an average cost of $42.97 per share, with a total value of $494,155.00. Following the transaction, the executive directly owned 13,773 shares in the company, valued at approximately $591,825.81. This trade represents a 505.94% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO C Taylor Pickett bought 20,000 shares of the business’s stock in a transaction on Wednesday, November 5th. The shares were bought at an average cost of $43.14 per share, for a total transaction of $862,800.00. Following the completion of the acquisition, the chief executive officer directly owned 20,000 shares in the company, valued at approximately $862,800. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 1.50% of the stock is currently owned by company insiders.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.